Houssiau FA
Houssiau FA
Professeur; IREC, SSS, Université catholique de Louvain
Email verificata su uclouvain.be
TitoloCitata daAnno
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M Rudwaleit, D Van Der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, ...
Annals of the rheumatic diseases 68 (6), 777-783, 2009
23262009
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
17052002
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ...
Medicine 82 (5), 299-308, 2003
12222003
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.
R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ...
Medicine 72 (2), 113-124, 1993
10381993
Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
FA Houssiau, JP Devogelaer, J Van Damme, CN De Deuxchaisnes, ...
Arthritis & Rheumatism 31 (6), 784-788, 1988
9401988
Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ...
Arthritis & Rheumatism 46 (8), 2121-2131, 2002
9322002
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6
B Klein, XG Zhang, M Jourdan, J Content, F Houssiau, L Aarden, ...
Blood 73 (2), 517-526, 1989
9111989
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of …
GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ...
Annals of the rheumatic diseases 71 (11), 1771-1782, 2012
7392012
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including …
GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ...
Annals of the rheumatic diseases 67 (2), 195-205, 2008
7362008
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ...
Annals of the rheumatic diseases 74 (6), 1011-1018, 2015
569*2015
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus …
R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ...
Medicine 78 (3), 167-175, 1999
5011999
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ...
Annals of the rheumatic diseases 69 (01), 61-64, 2010
4072010
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
FA Houssiau, D D'Cruz, S Sangle, P Remy, C Vasconcelos, R Petrovic, ...
Annals of the rheumatic diseases 69 (12), 2083-2089, 2010
3942010
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ...
Arthritis & rheumatism 50 (12), 3934-3940, 2004
3702004
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...
Annals of the rheumatic diseases 73 (6), 958-967, 2014
3362014
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
N Agmon-Levin, J Damoiseaux, C Kallenberg, U Sack, T Witte, M Herold, ...
Annals of the rheumatic diseases 73 (1), 17-23, 2014
3312014
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
TRDJ Radstake, O Gorlova, B Rueda, JE Martin, BZ Alizadeh, ...
Nature genetics 42 (5), 426, 2010
3202010
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
FA Houssiau, C Lefebvre, M Vanden Berghe, M Lambert, JP Devogelaer, ...
lupus 4 (5), 393-395, 1995
3201995
Antiphospholipid syndrome
R Cervera
Thrombosis research 151, S43-S47, 2017
318*2017
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis …
SB Cohen, LW Moreland, JJ Cush, MW Greenwald, S Block, WJ Shergy, ...
Annals of the rheumatic diseases 63 (9), 1062-1068, 2004
3132004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20